ABP 710

Amgen Announces Top-Line Data From Remicade Biosimilar Study
Yahoo/Zacks.com
Thu, 06/28/18 - 09:34 am
Amgen
ABP 710
JNJ
Merck
Remicade
biosimilars
rheumatoid arthritis